Abstract
Caspofungin, in association with other antifungal drugs, was administered as rescue therapy in two cases of documented and one case of possible invasive fungal infection in children with acute leukaemia or undergoing allogeneic bone marrow transplant. The combined therapy was well-tolerated and seemed to be effective in all three patients. A combination antifungal therapy including caspofungin could represent an effective therapy for children with invasive mycoses refractory to single-agent antifungal therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 255-257 |
| Number of pages | 3 |
| Journal | Clinical Microbiology and Infection |
| Volume | 10 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2004 |
Keywords
- Amphotericin B
- Bone marrow transplant
- Caspofungin
- Fungal pneumonia
- Leukaemia
- Voriconazole
ASJC Scopus subject areas
- Microbiology (medical)
- Microbiology
- Infectious Diseases
Fingerprint Dive into the research topics of 'Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant'. Together they form a unique fingerprint.
Cite this
Castagnola, E., Machetti, M., Cappelli, B., Molinari, A. C., Morreale, G., Dodero, P., Tomà, P., & Faraci, M. (2004). Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant. Clinical Microbiology and Infection, 10(3), 255-257. https://doi.org/10.1111/j.1198-743X.2004.00837.x